Notably, Saigusa et al. showed that rectal cancer patients who receive preoperative chemoradiotherapy are likely to develop tumor recurrence if the tumors express high levels of Sox2 mRNA18, which suggests resistance to treatment with radiation and chemotherapy via a Sox2-mediated mechanism. Here, SOX2 is linked to rectal cancer.